Walleye Capital’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Walleye Capital’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-21,997	Closed	-$4.62K	–	4429
2024 Q4	$4.62K	Sell	21,997 -179,472	-89%	-$36.7K	﹤0.01%	4628
2024 Q3	$38.3K	Hold	201,469	–	–	﹤0.01%	4697
2024 Q2	$42.3K	Hold	201,469	–	–	﹤0.01%	4977
2024 Q1	$50.4K	Hold	201,469	–	–	﹤0.01%	4675
2023 Q4	$38.8K	Hold	201,469	–	–	﹤0.01%	4358
2023 Q3	$53.5K	Hold	201,469	–	–	﹤0.01%	4177
2023 Q2	$79.6K	Hold	201,469	–	–	﹤0.01%	3500
2023 Q1	$65.8K	Hold	201,469	–	–	﹤0.01%	3108
2022 Q4	$50.4K	Hold	201,469	–	–	﹤0.01%	2518
2022 Q3	$90K	Sell	201,469 -2,816	-1%	-$1.66K	﹤0.01%	2458
2022 Q2	$98K	Buy	204,285 +20,096	+11%	+$11.2K	﹤0.01%	1754
2022 Q1	$112K	Buy	+184,189	New	+$100K	﹤0.01%	1715

Other funds holding DRTSW

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

Value Base Tel Aviv, Israel $162M AUM 2.31% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Walleye Capital's DRTSW Position: Q1 2025 in Review

Walleye Capital sold out of Alpha Tau Medical Warrant (DRTSW) in Q1 2025, closing a stake of 21,997 shares — an estimated $4.62K sold.

Walleye Capital first reported a position in DRTSW in Q1 2022 and held it in 12 quarters. The position peaked at $112K in Q1 2022. 23 funds tracked by Wall St. Rank hold DRTSW as of Q1 2025.

Walleye Capital reported no remaining Alpha Tau Medical Warrant position as of Q1 2025 after selling out during the quarter.
Walleye Capital sold 21,997 Alpha Tau Medical Warrant shares in Q1 2025, an estimated $4.62K.
Walleye Capital first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 12 quarters.
Walleye Capital's Alpha Tau Medical Warrant position peaked at $112K in Q1 2022.
23 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.